NCT04809662 2024-11-07Comparing Immune Responses to Topical ImiquimodUniversity of California, DavisTerminated6 enrolled
NCT01806961 2016-08-03Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.Spirig Pharma Ltd.Terminated16 enrolled 4 charts